Effect of yokukansan on memory disturbance in an animal model of cerebrovascular dementia
Yokukansan (YKS) is a traditional Japanese herbal medicine, which was reported to improve the behavioral and psychological symptoms of dementia (BPSD). However, the effect of YKS on memory dysfunction remains unknown. In this study, we examined the effect of YKS on impaired spatial memory in rats su...
Saved in:
Published in | Journal of Traditional Medicines Vol. 30; no. 4; pp. 164 - 175 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | Japanese |
Published |
和漢医薬学会
2013
Medical and Pharmaceutical Society for WAKAN-YAKU |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Yokukansan (YKS) is a traditional Japanese herbal medicine, which was reported to improve the behavioral and psychological symptoms of dementia (BPSD). However, the effect of YKS on memory dysfunction remains unknown. In this study, we examined the effect of YKS on impaired spatial memory in rats subjected to repeated cerebral ischemia, a well-established animal model for cerebrovascular dementia. Additionally, we compared the effect of YKS and donepezil (DPZ) on cholinergic dysfunction and hippocampal CA1 neuronal death in rats subjected to repeated cerebral ischemia. Spatial memory, as assessed using the eight-arm radial maze task, was impaired by repeated cerebral ischemia and significantly improved following administration of YKS (100, 300, 1000 mg/kg per day, p.o. for 14 days before and after ischemia treatment. Furthermore, a significant improvement was observed following additional 7-day treatment with YKS (1000 mg/kg per day, p.o.) after ischemia. YKS treatment was comparable to DPZ (10 mg/kg per day, p.o.) after ischemia. Microdialysis studies showed that spontaneous release of acetylcholine (ACh) from the dorsal hippocampus was significantly reduced following repeated cerebral ischemia. However, treatment with YKS or DPZ increased spontaneous ACh release following repeated cerebral ischemia. In contrast, hippocampal apoptosis, which developed after repeated ischemia, was suppressed by YKS, but not by DPZ. Overall, we found that YKS improves spatial memory disturbance via its unique character of having both an increasing effect on ACh release and a neuroprotective effect, which will be useful not only for BPSD but also memory dysfunction in cerebrovascular dementia patients. |
---|---|
AbstractList | Yokukansan (YKS) is a traditional Japanese herbal medicine, which was reported to improve the behavioral and psychological symptoms of dementia (BPSD). However, the effect of YKS on memory dysfunction remains unknown. In this study, we examined the effect of YKS on impaired spatial memory in rats subjected to repeated cerebral ischemia, a well-established animal model for cerebrovascular dementia. Additionally, we compared the effect of YKS and donepezil (DPZ) on cholinergic dysfunction and hippocampal CA1 neuronal death in rats subjected to repeated cerebral ischemia. Spatial memory, as assessed using the eight-arm radial maze task, was impaired by repeated cerebral ischemia and significantly improved following administration of YKS (100, 300, 1000 mg/kg per day, p.o. for 14 days before and after ischemia treatment. Furthermore, a significant improvement was observed following additional 7-day treatment with YKS (1000 mg/kg per day, p.o.) after ischemia. YKS treatment was comparable to DPZ (10 mg/kg per day, p.o.) after ischemia. Microdialysis studies showed that spontaneous release of acetylcholine (ACh) from the dorsal hippocampus was significantly reduced following repeated cerebral ischemia. However, treatment with YKS or DPZ increased spontaneous ACh release following repeated cerebral ischemia. In contrast, hippocampal apoptosis, which developed after repeated ischemia, was suppressed by YKS, but not by DPZ. Overall, we found that YKS improves spatial memory disturbance via its unique character of having both an increasing effect on ACh release and a neuroprotective effect, which will be useful not only for BPSD but also memory dysfunction in cerebrovascular dementia patients. [Abstract] Yokukansan (YKS) is a traditional Japanese herbal medicine, which was reported to improve the behavioral and psychological symptoms of dementia (BPSD). However, the effect of YKS on memory dysfunction remains unknown. In this study, we examined the effect of YKS on impaired spatial memory in rats subjected to repeated cerebral ischemia, a well-established animal model for cerebrovascular dementia. Additionally, we compared the effect of YKS and donepezil (DPZ) on cholinergic dysfunction and hippocampal CA1 neuronal death in rats subjected to repeated cerebral ischemia. Spatial memory, as assessed using the eight-arm radial maze task, was impaired by repeated cerebral ischemia and significantly improved following administration of YKS (100, 300, 1000 mg/kg per day, p.o. for 14 days before and after ischemia treatment. Furthermore, a significant improvement was observed following additional 7-day treatment with YKS (1000 mg/kg per day, p.o.) after ischemia. YKS treatment was comparable to DPZ (10mg/kg per day, p.o.) after ischemia. Microdialysis studies showed that spontaneous release of acetylcholine (ACh) from the dorsal hippocampus was significantly reduced following repeated cerebral ischemia. However, treatment with YKS or DPZ increased spontaneous ACh release following repeated cerebral ischemia. In contrast, hippocampal apoptosis, which developed after repeated ischemia, was suppressed by YKS, but not by DPZ. Overall, we found that YKS improves spatial memory disturbance via its unique character of having both an increasing effect on ACh release and a neuroprotective effect, which will be useful not only for BPSD but also memory dysfunction in cerebrovascular dementia patients. |
Author | Kotaro Takasakia b Shutaro Katsurabayashia Naoki Uchidac Michihiro Fujiwaraa Ai Nogamia Risako Fujikawaa Kaori Kubotaa Katsunori Iwasakia Kenichi Mishimaa Kazuya Nakamuraa Chihiro Kawasakia Ryoji Nishimurab Kazuko Yamaguchia |
Author_xml | – sequence: 1 fullname: Ai Nogamia – sequence: 2 fullname: b – sequence: 3 fullname: Kotaro Takasakia – sequence: 4 fullname: Kaori Kubotaa – sequence: 5 fullname: Kazuko Yamaguchia – sequence: 6 fullname: Chihiro Kawasakia – sequence: 7 fullname: Kazuya Nakamuraa – sequence: 8 fullname: Risako Fujikawaa – sequence: 9 fullname: Naoki Uchidac – sequence: 10 fullname: Shutaro Katsurabayashia – sequence: 11 fullname: Kenichi Mishimaa – sequence: 12 fullname: Ryoji Nishimurab – sequence: 13 fullname: Michihiro Fujiwaraa – sequence: 14 fullname: Katsunori Iwasakia |
BookMark | eNo1UMtKxTAQDaKgXl35A_mB6qRJmnbhQsQXCG504SpM06m2NomkucL9e1sfcDhnZuCcYeaY7YcYiLEzAedCSNlcjNmfy6Wp1B47EnUtCmmU2f-poRBKmUN2Os9DC1CqWmlZH7HXm74nl3ns-S5-bD8wzBh4DNyTj2nHu2HO29RicMSHwHHF4HHiPnY0rTZHidoUv3B22wkT78hTyAOesIMep5lO_3TDXm5vnq_vi8enu4frq8diVFDlAhuAqjMVlabTpex7qITWtWnqRreiaisUPYGrSBtS1AiSXaNVj20rutpIlBt295vrqRscTjFMQyA7xm0Ky17rgs4JPdkShLQAEkCtYmF51EJGl2JBA0vS5W_SOGd8I_uZlkvTzmLKg5uWyOytBKtWWr3_c_eOyY4ovwGeuHdo |
ContentType | Journal Article |
Copyright | 2013 Medical and Pharmaceutical Society for WAKAN-YAKU |
Copyright_xml | – notice: 2013 Medical and Pharmaceutical Society for WAKAN-YAKU |
CorporateAuthor | cDepartment of Psychiatry bInstitute for Aging and Brain Sciences Fukuoka University School of Medicine aDepartment of Neuropharmacology Faculty of Pharmaceutical Science Fukuoka University |
CorporateAuthor_xml | – name: cDepartment of Psychiatry – name: Fukuoka University – name: bInstitute for Aging and Brain Sciences – name: Fukuoka University School of Medicine – name: Faculty of Pharmaceutical Science – name: aDepartment of Neuropharmacology |
DOI | 10.11339/jtm.30.164 |
DatabaseTitleList | |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 1881-3747 |
EndPage | 175 |
ExternalDocumentID | cn5trame_2013_003004_003_0164_01752152190 article_jtm_30_4_30_164_article_char_ja |
GroupedDBID | .L7 .LE 2WC ALMA_UNASSIGNED_HOLDINGS JMI KQ8 MOJWN OK1 P2P RJT RYR RZJ TKC |
ID | FETCH-LOGICAL-j406t-a9006d76e27d523ff06155879895b16b6a1fe0c6e57e4e91e3d954fabb1d873a3 |
ISSN | 1880-1447 |
IngestDate | Fri Nov 08 06:53:07 EST 2024 Wed Apr 05 04:14:50 EDT 2023 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Language | Japanese |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-j406t-a9006d76e27d523ff06155879895b16b6a1fe0c6e57e4e91e3d954fabb1d873a3 |
OpenAccessLink | https://www.jstage.jst.go.jp/article/jtm/30/4/30_164/_article/-char/ja |
PageCount | 12 |
ParticipantIDs | medicalonline_journals_cn5trame_2013_003004_003_0164_01752152190 jstage_primary_article_jtm_30_4_30_164_article_char_ja |
PublicationCentury | 2000 |
PublicationDate | 2013-00-00 |
PublicationDateYYYYMMDD | 2013-01-01 |
PublicationDate_xml | – year: 2013 text: 2013-00-00 |
PublicationDecade | 2010 |
PublicationTitle | Journal of Traditional Medicines |
PublicationTitleAlternate | Journal of Traditional Medicines |
PublicationYear | 2013 |
Publisher | 和漢医薬学会 Medical and Pharmaceutical Society for WAKAN-YAKU |
Publisher_xml | – name: 和漢医薬学会 – name: Medical and Pharmaceutical Society for WAKAN-YAKU |
References | 1)Gonzlez-Concepcin, J.J., Geil, K., Jimnez-Velzquez, I.Z., Ramos-Romey, C.: Atypical antipsychotics in the management of behavioral symptoms associated with dementia. Bol. Asoc. Med. P R., 101(1), 51-53, 2009. 15)Pulsinelli, W.A., Brierley, J.B.: A new model of bilateral hemispheric ischemia in the unanesthetized rat. Stroke, 10(3), 267-272, 1979. 22)Irie, K., Mishima, K., Ishibashi, D., Egashira, N., Iwasaki, K., Fujiwara, M.: Involvement of bcl-family expression in the spatial memory impairment induced by repeated ischemia. Life Sci., 72(4-5), 621-629, 2002. 10)Hayashi, Y., Ishida, Y., Inoue, T., Udagawa, M., Takeuchi, K., Yoshimuta, H., Kiue, K., Ninomiya, Y., Kawano, J., Sameshima, T., Kawahara, T., Goto, I., Shudo, K., Kurayama, S., Nakamura, J., Okahara, K., Mitsuyama, Y.: Treatment of behavioral and psychological symptoms of Alzheimer-type dementia with Yokukansan in clinical practice. Prog. Neuropsychopharmacol. Biol. Psychiatry, 34(3), 541-545, 2010. 23)Hatip-Al-Khatib, I., Iwasaki, K., Egashira, N., Ishibashi, D., Mishima, K., Fujiwara, M.: Comparison of single- and repeated-ischemia-induced changes in expression of flip and flop splice variants of AMPA receptor subtypes GluR1 and GluR2 in the rats hippocampus CA1 subregion. J. Pharmacol. Sci., 103(1), 83-91, 2007. 21)Uchida, N., Takasaki, K., Sakata, Y., Nogami, A., Oishi, H., Watanabe, T., Shindo, T., Egashira, N., Kubota, K., Katsurabayashi, S., Mishima, K., Fujiwara, M., Nishimura, R., Iwasaki, K.: Cholinergic Involvement and Synaptic Dynamin 1 Expression in Yokukansan-mediated Improvement of Spatial Memory in a Rat Model of Early Alzheimer's Disease. Phytother Res., 27(7), 966-972, 2013. 8)Terawaki, K., Ikarashi, Y., Sekiguchi, K., Nakai, Y., Kase, Y.: Partial agonistic effect of yokukansan on human recombinant serotonin 1A receptors expressed in the membranes of Chinese hamster ovary cells. J Ethnopharmacol, 127(2), 306-312, 2010. 11)Baskys, A., Hou, A.C.: Vascular dementia: pharmacological treatment approaches and perspectives. Clin. Interv. Aging, 2(3), 327-335, 2007. 6)Monji, A., Takita, M., Samejima, T., Takaishi, T., Hashimoto, K., Matsunaga, H., Oda, M., Sumida, Y., Mizoguchi, Y., Kato, T., Horikawa, H., Kanba, S.: Effect of yokukansan on the behavioral and psychological symptoms of dementia in elderly patients with Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry, 33, 308-311, 2009. 3)Iwasaki, K., Satoh-Nakagawa, T., Maruyama, M., Monma, Y., Nemoto, M., Tomita, N., Tanji, H., Fujiwara, H., Seki, T., Fujii, M., Arai, H., Sasaki, H.: A randomized, observer-blind, controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients. J. Clin. Psychiatry, 66(2), 248-252, 2005. 12)Iwasaki, K., Egashira, N., Hatip-Al-Khatib, I., Akiyoshi, Y., Arai, T., Takagaki, Y., Watanabe, T., Mishima, K., Fujiwara, M.: Cerebral ischemia combined with beta-amyloid impairs spatial memory in the eight-arm radial maze task in rats. Brain Res., 1097(1), 216-223, 2006. 20)Chung, E., Iwasaki, K., Mishima, K., Egashira, N., Fujiwara, M.: Repeated cerebral ischemia induced hippocampal cell death and impairments of spatial cognition in the rat. Life Sci., 72(4-5), 609-619, 2002. 19)Lippa, A.S., Pelham, R.W., Beer, B., Critchett, D.J., Dean, R.L., Bartus, R.T.: Brain cholinergic dysfunction and memory in aged rats. Neurobiol Aging, 1(1), 13-19, 1980. 26)Terasawa, K., Shimada, Y., Kita, T., Yamamoto, T., Tosa, H., Tanaka, N., Saito, Y., Kanaki, E., Goto, S., Mizushima, N., Fujioka, M., Takase, S., Seki, H., Kimura, I., Ogawa, T., Nakamura, S., Araki, G., Maruyama, I., Maruyama, Y., Takaori, S.: Choto-san in the treatment of vascular dementia: a double-blind, placebo-controlled study. Phytomedicine, 4(1), 15-22, 1997. 4)Mizukami, K., Asada, T., Kinoshita, T., Tanaka, K., Sonohara, K., Nakai, R., Yamaguchi, K., Hanyu, H., Kanaya, K., Takao, T., Okada, M., Kudo, S., Kotoku, H., Iwakiri, M., Kurita, H., Miyamura, T., Kawasaki, Y., Omori, K., Shiozaki, K., Odawara, T., Suzuki, T., Yamada, S., Nakamura, Y., Toba, K.: A randomized cross-over study of a traditional Japanese medicine (kampo), yokukansan, in the treatment of the behavioural and psychological symptoms of dementia. Int J Neuropsychopharmacol., 12(2), 191-199, 2009. 14) Iwasaki, K., Chung, E.H., Egashira, N., Hatip-Al-Khatib, I., Mishima, K., Egawa, T., Irie, K., Fujiwara, M.: Non-NMDA mechanism in the inhibition of cellular apoptosis and memory impairment induced by repeated ischemia in rats. Brain Res., 995(1), 131-139, 2004. 13)Olton, D.S., Samuelson, R.J.: Remembrance of places past:spatial memory in rats. J. Exp. Psychol., Anim. Behav. Processes, 2, 97-116, 1976. 5)Miyaoka, T., Furuya, M., Yasuda, H., Hayashida, M., Nishida, A., Inagaki, T., Horiguchi, J.: Yi-gan san for the treatment of neuroleptic-induced tardive dyskinesia: an open-label study. Prog. Neuropsychopharmacol. Biol. Psychiatry, 32, 761-764, 2008. 25)Kawakami, Z., Kanno, H., Ueki, T., Terawaki, K., Tabuchi, M., Ikarashi, Y., Kase, Y.: Neuroprotective effects of yokukansan, a traditional Japanese medicine, on glutamate-mediated excitotoxicity in cultured cells. Neuroscience, 159(4), 1397-1407, 2009. 17)Campanozzi, M.D., Casali, E., Neviani, F., Martini, E., Neri, M.: Evaluation of the slopes of cognitive impairment and disability in Alzheimer's disease (AD) patients treated with acetylcholinesterase inhibitors (AChEl). Arch. Gerontol. Geriatr, 44, 91-96, 2007. 2)Rogers, S.L., Friedhoff, L.T.: The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US multicenter, randomized, double-blind, placebo-controlled trial. The Donepezil Study Group. Dementia, 7(6), 293-303, 1996. 16)Nogami, A., Takasaki, K., Sakata, Y., Uchida, N., Yamaguchi, K., Kawasaki, C., Shindo, T., Katsurabayashi, S., Mishima, K., Nishimura, R., Fujiwara, M., Iwasaki, K.: Effects of Yokukansan on the anxiety-like behavior in model rat of cerebrovascular dementia. J Nat Med., 65(2), 275-281, 2011. 9)Uchida, N., Egashira, N., Iwasaki, K., Ishibashi, A., Tashiro, R., Nogami, A., Manome, N., Abe, M., Takasaki, K., Mishima, K., Takata, J., Oishi, R., Nishimura, R., Fujiwara, M.: Yokukansan inhibits social isolation-induced aggression and methamphetamine-induced hyperlocomotion in rodents. Biol Pharm Bull., 32(3), 372-375, 2009. 7)Egashira, N., Iwasaki, K., Ishibashi, A., Hayakawa, K., Okuno, R., Abe, M., Uchida, N., Mishima, K., Takasaki, K., Nishimura, R., Oishi, R., Fujiwara, M.: Repeated administration of Yokukansan inhibits DOI-induced head-twitch response and decreases expression of 5-hydroxytryptamine (5-HT) 2A receptors in the prefrontal cortex. Prog Neuropsychopharmacol. Biol. Psychiatry, 32(6), 1516-1520, 2008. 27)Goto, H., Satoh, N., Hayashi, Y., Hikiami, H., Nagata, Y., Obi, R., Shimada, Y.: A chinese herbal medicine, tokishakuyakusan, reduces the worsening of impairments and independence after stroke: a 1-year randomized, controlled trial. Evid Based Complement Alternat Med., 2011, 194046, 2011. 24)Sugimoto, H., Iimura, Y., Yamanishi, Y., Yamatsu, K.: Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-[(5,6-dimethoxy-1-oxoindan-2-yl)methyl]piperidine hydrochloride and related compounds. J Med Chem., 38, 4821-4829, 1995. 18)Romn, G.C., Salloway, S., Black, S.E., Royall, D.R., Decarli, C., Weiner, M.W., Moline, M., Kumar, D., Schindler, R., Posner, H.: Randomized, placebo-controlled, clinical trial of donepezil in vascular dementia: differential effects by hippocampal size. Stroke, 41(6), 1213-1221, 2010. |
References_xml | |
SSID | ssib002484538 ssib000936303 ssj0052675 ssib002224288 ssib023157187 |
Score | 1.9266369 |
Snippet | Yokukansan (YKS) is a traditional Japanese herbal medicine, which was reported to improve the behavioral and psychological symptoms of dementia (BPSD).... [Abstract] Yokukansan (YKS) is a traditional Japanese herbal medicine, which was reported to improve the behavioral and psychological symptoms of dementia... |
SourceID | medicalonline jstage |
SourceType | Publisher |
StartPage | 164 |
SubjectTerms | Acetylcholine Apoptosis Dementia Memory Yokukansan |
Title | Effect of yokukansan on memory disturbance in an animal model of cerebrovascular dementia |
URI | https://www.jstage.jst.go.jp/article/jtm/30/4/30_164/_article/-char/ja http://mol.medicalonline.jp/library/journal/download?GoodsID=cn5trame/2013/003004/003&name=0164-0175e |
Volume | 30 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Journal of Traditional Medicines, 2013, Vol.30(4), pp.164-175 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3fb9MwELbKeEFCCASIjYH8wFuVksRxnLwtQqCJahVIrdieIjtxIKmSoC59GP8E_zJ3sZum_JAGSJHbuomV-C7nz-e7z4S8knEmoiLIHZlFrhOISDqxcJWjGAynmeaZ7jPkLhbh-Sp4f8kvJ5Pvo6ilbadm2bff5pX8i1ShDuSKWbJ_IdmhUaiA7yBfKEHCUN5KxpZ6GPDeTbvernHn7wa9_zWGz97g4gsMKKpPCigx6BiOssZ0Edz-pg8o1xuYE-_DUfPeWVjKP0BWGNjy0joPL-yi_IDJk3K6aD_LuhwMvRqsedvJTTtdyrW8BsQ6nDCX7aaczrcK_pdj_4NJHJ3ZfL2B0ODDlwMH_Dji9FMyTxbOVTJfjcwsWA0HpnJibIft-kw5djL0RtUzPOd2fPbMTiu_mn7GkDq16uoZg5-7aw64tLOGdxjzluKDIC0qKBN-pEg0BoXguM0vYKQ75K4PlgtjROcfR3g1ZiEbL1sDAPL3fG-AlTmM9cOMn_thz_Q8PK5NEMVbfb2_UQA_FUwFkOPhfm061dCkjJDO8iF5YOVNE6Nvj8ikko_JldE12hZ0r2u0bajRNTrSNVo2VOKBukZ7XcPLftI1utO1J2T17u3yzbljt-VwKkB_nSNjsNS5CLUvcu6zokBUzCMRRzFXXqhC6RXazULNhQ507GmWxzwopFJeHgkm2VNy1LSNfkaoq3MZsiwSWomgUEJCc4HSgWTKc6GJYxKankm_Gu6V1L5rKfReytw0wAJlt6vHXMW0ksfk7KAnU_vWXqe3VoGT_2_iObnn97unoMfulBx1m61-ARi2Uy97vfoBicecRg |
link.rule.ids | 315,783,787,4031,27935,27936,27937 |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effect+of+yokukansan+on+memory+disturbance+in+an+animal+model+of+cerebrovascular+dementia&rft.jtitle=Journal+of+Traditional+Medicines&rft.au=Ai+Nogamia&rft.au=b&rft.au=Kotaro+Takasakia&rft.au=Kaori+Kubotaa&rft.date=2013&rft.pub=Medical+and+Pharmaceutical+Society+for+WAKAN-YAKU&rft.issn=1880-1447&rft.volume=30&rft.issue=4&rft.spage=164&rft.epage=175&rft_id=info:doi/10.11339%2Fjtm.30.164&rft.externalDocID=cn5trame_2013_003004_003_0164_01752152190 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1880-1447&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1880-1447&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1880-1447&client=summon |